Antihypertensive effects of angiotensin fragments in SHR

Biosci Biotechnol Biochem. 1995 Aug;59(8):1398-401. doi: 10.1271/bbb.59.1398.

Abstract

When angiotensin fragments, Val-Tyr and Angiotensin III (ANG III), with potent ACE inhibitory activity were intravenously administered to spontaneously hypertensive rat (SHR), a significant reduction of diastolic blood pressure was observed. After incubation of ANG III with SHR plasma, four fragments with ACE inhibitory activity, Val-Tyr (ANG (3-4)) (IC50 = 26.0 microM), Ile-His-Pro-Phe (ANG (5-8)) (11.6 microM), Tyr-Ile-His-Pro-Phe (ANG (4-8)) (457.5 microM), and Val-Tyr-Ile-His-Pro-Phe (ANG (3-8)) (6.55 microM), were confirmed to generate in SHR plasma. Compared the metabolic behavior of ANG II in SHR plasma with that in normotensive Wistar plasma, the initial degradation rate (3.07 nmol/ml/min) in Wistar plasma was about 2-fold higher than that in the SHR one (1.75 nmol/ml/min).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Angiotensin II / metabolism
  • Angiotensin II / pharmacology*
  • Angiotensin III / pharmacology*
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Animals
  • Antihypertensive Agents / pharmacology*
  • Blood Pressure
  • Hypertension
  • Male
  • Molecular Sequence Data
  • Peptide Fragments / pharmacology*
  • Peptidyl-Dipeptidase A / metabolism
  • Rats
  • Rats, Inbred SHR
  • Structure-Activity Relationship

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Peptide Fragments
  • Angiotensin II
  • Angiotensin III
  • Peptidyl-Dipeptidase A